Glimepiride, a Novel Sulfonylurea, Does Not Abolish Myocardial Protection Afforded by Either Ischemic Preconditioning or Diazoxide

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-06-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.103.25.3111PMID 11425777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.

  2009cited by this paper
• Meeting Report: Hatter Institute Workshop on Myocardial Preconditioning

  2004cited by this paper
• Diabetes, coronary heart disease and sulphonylureas-not the final word.

  2000cited by this paper
• Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function.

  2000cited by this paper
• Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives.

  1999cited by this paper
• Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.

  1999cited by this paper
• Mitochondrial ATP‐Dependent Potassium Channels: Viable Candidate Effectors of Ischemic Preconditioning a

  1999cited by this paper
• Import and processing of heart mitochondrial cyclophilin D.

  1999cited by this paper
• Improved knowledge of antidiabetic treatment--a necessity for the modern cardiologist.

  1999cited by this paper
• A Na+-activated K+ current (IK,Na) is present in guinea-pig but not rat ventricular myocytes

  1999cited by this paper
• Hatter Institute Workshop on Myocardial Preconditioning, Cape Town, April 1998

  1998cited by this paper
• Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function.

  1998cited by this paper
• Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?

  1998cited by this paper
• Mitochondrial ATP-sensitive K1 channels modulate cardiac mitochondrial function

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate.

  1998cited by this paper
• Ischaemic preconditioning: present position and future directions.

  1998cited by this paper
• Direct effects of diazoxide on mitochondria in pancreatic B‐cells and on isolated liver mitochondria

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.

  1997cited by this paper
• Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.

  1997cited by this paper
• The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010

  1997cited by this paper
• Direct Effects of Glimepiride on Protein Expression of Cardiac Glucose Transporters

  1996cited by this paper
• Cardiovascular Effects of Conventional Sulfonylureas and Glimepiride

  1996cited by this paper
• Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration.

  1996cited by this paper
• Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

  1996cited by this paper
• Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker

  1994cited by this paper
• ATP-sensitive K+ channel in the mitochondrial inner membrane

  1991cited by this paper
• Special pharmacology of the new sulfonylurea glimepiride.

  1988cited by this paper
• Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

  1986cited by this paper
• A Study of the Effects of Hypoglycemic Agents on Vascular Complications in Patients with Adult-onset Diabetes: VI. Supplementary Report on Nonfatal Events in Patients Treated with Tolbutamide

  1976cited by this paper
• University group diabetes program.

  1971cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper

• Combining Sulfonylureas with Anticancer Drugs: Evidence of Synergistic Efficacy with Doxorubicin In Vitro and In Vivo

  2025cites this paper
• To Develop RP-HPLC Method to Estimate Glimperide in Bulk Dosage Forms

  2025cites this paper
• DEVELOPMENT AND VALIDATION OF A NOVEL STABILITY-INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF AMLODIPINE, GLIMEPIRIDE AND PERINDOPRIL ARGININE

  2024cites this paper
• A Review on Invitro Evolution of Glimepiride Tablets

  2023cites this paper
• Hinokitiol produces vasodilation in aortae from normal and angiotensin II- induced hypertensive rats via endothelial-dependent and independent pathways.

  2022cites this paper
• Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery – A Meta-Analysis

  2022cites this paper
• Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning

  2022cites this paper
• Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols

  2020cites this paper
• Treatment of Patients with Heart failure and Type 2 Diabetes: a review of the literature

  2019cites this paper
• In-vitro – In-vivo Characterization of Glimepiride Lipid Nanoparticulates Prepared by Combined Approach of Precipitation and Complexation

  2019cites this paper
• Diabetes and Cardiovascular Disease

  2019cites this paper
• Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group

  2019cites this paper
• Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: a single-center, double-blind, randomized controlled trial

  2019cites this paper
• Conditioning of the Myocardium

  2019cites this paper
• Treatment with Oral Drugs

  2018cites this paper
• Pharmacotherapy of type 2 diabetes: An update.

  2018cites this paper
• Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.

  2017cites this paper
• Evaluation of the relaxant effect of levetiracetam on isolated rat duodenum

  2017cites this paper
• Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes

  2017cites this paper
• Metabolomic analysis of healthy human urine following administration of glimepiride using a liquid chromatography-tandem mass spectrometry

  2017cites this paper
• Role of conventional oral antidiabetic drugs in management of type 2 diabetes mellitus

  2017cites this paper
• Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial - START Study

  2017cites this paper
• Factors Affecting The Cardioprotective Response To Remote Ischaemic Preconditioning In Patients Undergoing Cardiac Surgery

  2017cites this paper
• Case–control study of oral glucose‐lowering drugs in combination with long‐acting insulin and the risks of incident myocardial infarction and incident stroke

  2016influential citation
• Cardiovascular effects of anti-diabetes drugs

  2016cites this paper
• Is gliclazide a sulfonylurea with difference? A review in 2016

  2016cites this paper
• Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.

  2015cites this paper
• Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

  2015influential citation
• Emerging treatments for post-transplantation diabetes mellitus

  2015cites this paper
• The role of glimepiride in combination with metformin in modern practice of using antihyperglycemic therapy for type 2 diabetes mellitus

  2015cites this paper
• Pharmacological cardioprotection in diabetes

  2015cites this paper
• Myocardial protection by remote ischaemic pre‐conditioning is abolished in sulphonylurea‐treated diabetics undergoing coronary revascularisation

  2014cites this paper
• Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes

  2014cites this paper
• Myocardial ischaemia and infarction

  2014cites this paper
• Impact of hypoglycemic agents on myocardial ischemic preconditioning.

  2014cites this paper
• Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle

  2014cites this paper
• Cell Survival Programs and Ischemia/Reperfusion: Hormesis, Preconditioning, and Cardioprotection

  2013cites this paper
• Sulfonylureas and meglitinides: historical and contemporary issues.

  2013cites this paper
• Corrected QT Interval Prolongation during Severe Hypoglycemia without Hypokalemia in Patients with Type 2 Diabetes

  2013cites this paper
• Glimepiride Treatment Facilitates Ischemic Preconditioning in the Diabetic Heart

  2013cites this paper
• Clinical Trials to Clinical Practice : Role of Sulfonylureas in Today ’ s Practice

  2013cites this paper
• Роль препаратов сульфонилмочевины в развитии сердечно-сосудистых осложнений при сахарном диабете 2 типа

  2012cites this paper
• Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning

  2012cites this paper
• Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

  2012cites this paper
• Glimepiride: evidence-based facts, trends, and observations

  2012cites this paper
• Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population

  2012cites this paper
• Ischaemic Preconditioning and Outcomes After Angioplasty

  2012influential citation
• Modern antihyperglycemic therapy: safety and efficacy of glimepiride

  2012cites this paper
• Глимепирид в современной гипогликемизирующей терапии: безопасность и эффективность

  2012cites this paper
• Variations in tissue selectivity amongst insulin secretagogues: a systematic review

  2012cites this paper
• The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury

  2011cites this paper
• Sarcolemmal KATP channel modulators and cardiac arrhythmias.

  2011cites this paper
• Влияние никорандила на частоту сердечно-сосудистых событий у пациентов с коронарной болезнью сердца - участников исследования JCAD (Japanese coronary artery disease Study)

  2011cites this paper
• Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery. -A randomized controlled trial-.

  2011cites this paper
• Treatment Strategy for Diabetes with Cardiovascular Disease

  2011cites this paper
• CARDIOPROTECTION BY VOLATILE ANESTHETICS: FROM BENCH TO BEDSIDE AND BACK

  2011cites this paper
• Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial.

  2011cites this paper
• Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.

  2011cites this paper
• Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction--a nationwide study.

  2011cites this paper
• Mitochondrial Uncoupling Agents Trigger Ventricular Fibrillation in Isolated Rat Hearts

  2011cites this paper
• Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

  2010cites this paper
• The role of glimepiride in the treatment of type 2 diabetes mellitus

  2010cites this paper
• Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study

  2010cites this paper
• The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy

  2010cites this paper
• Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.

  2010influential citation
• More reasons to say goodbye to glyburide.

  2010cites this paper
• Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study.

  2010cites this paper
• Preconditioning the diabetic human myocardium

  2009cites this paper
• Consequences of Delaying Progression to Optimal Therapy in Patients with Type 2 Diabetes Not Achieving Glycemic Goals

  2009cites this paper
• Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population‐based follow‐up study

  2009cites this paper
• Glimepiride treatment upon reperfusion limits infarct size via the phosphatidylinositol 3-kinase/Akt pathway in rabbit hearts.

  2009cites this paper
• The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.

  2009cites this paper
• Safe Oral Antidiabetic Agents in Cardiac Patients: An Update

  2009cites this paper
• SECOND-GENERATION SULFONYLUREAS PRESERVE INHIBITION OF MITOCHONDRIAL PERMEABILITY TRANSITION BY THE MITOCHONDRIAL K+ATP OPENER NICORANDIL IN EXPERIMENTAL MYOCARDIAL INFARCTION

  2009cites this paper
• Potential of glucose-lowering drugs to reduce cardiovascular events

  2009cites this paper
• Endogenous Activation of Mitochondrial KATP Channels Protects Human Failing Myocardium From Hydroxyl Radical–Induced Stunning

  2009cites this paper
• The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel

  2008cites this paper
• New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond.

  2008cites this paper
• Oral Glyburide, But Not Glimepiride, Blocks the Infarct-Size Limiting Effects of Pioglitazone

  2008cites this paper
• Optimizing Antidiabetic Treatment Options for Patients with Type 2 Diabetes Mellitus and Cardiovascular Comorbidities

  2008cites this paper
• Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea

  2008cites this paper
• Preconditioning and postconditioning: new strategies for cardioprotection

  2008cites this paper
• Nutritional level and energetic source are determinants of elevated circulatory lipohydroperoxide concentration

  2008cites this paper
• Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.

  2007cites this paper
• ‘Warm-up’ phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas

  2007cites this paper
• Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities.

  2007cites this paper
• Adenosine in health and disease. A human in vivo study on genetic, metabolic, and pharmacological determinants of the cardiovascular effects of adenosine.

  2007cites this paper
• Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?

  2007cites this paper
• Mitiglinide, a novel oral hypoglycemic agent, preserves the cardioprotective effect of ischemic preconditioning in isolated perfused rat hearts.

  2007cites this paper
• Pharmacological preconditioning with diazoxide slows energy metabolism during sustained ischemia.

  2007cites this paper
• A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes

  2007cites this paper
• Pharmacotherapy of Diabetes

  2007cites this paper
• The Place of Insulin Secretagogues in the Treatment of Type 2 Diabetes in the Twenty-First Century

  2007cites this paper
• Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning

  2007cites this paper
• MitoKATP-dependent changes in mitochondrial volume and in complex II activity during ischemic and pharmacological preconditioning of langendorff-perfused rat heart

  2006cites this paper
• The effect of nicorandil and glibenclamide on ischemic heart diseases

  2006cites this paper
• Review: Sulphonylureas and cardiovascular risk: facts and controversies

  2006cites this paper
• Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment

  2006cites this paper
• Myocardial Protection — From Concepts to Clinical Practice

  2006cites this paper
• Effects of sulfonylureas on mitochondrial ATP‐sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy

  2006cites this paper